Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
March 24, 2022

Unilabs sale completes

AP Moller Holding, the investment company owned by the billionaire Maersk family, has closed the purchase of global lab and imaging chain Unilabs. 
March 23, 2022

Icade Sante considering H2 for IPO attempt part deux

At the end of last year, healthcare specialist REIT Icade Santé looked to fall victim to capital markets' apathy for European healthcare services, postponing its IPO. Could it be looking to try again in H2 2022 - or is it too soon to try?
March 23, 2022

Circle Health sponsors work visas for Ukrainian refugees fleeing war

For-profit UK hospital groups are working on their responses to the humanitarian crisis in Ukraine. Circle Health is to sponsor up to 500 work visas for Ukrainian refugees across its 54 sites in the UK. We find out more about the plan, and approach other large providers in the UK to find out what they are doing.
March 23, 2022

IHH Healthcare shows growth

Malaysia and Singapore based Asia-focussed IHH Healthcare’s 2021 results show dynamic growth. Turkish groups are being impacted by the depreciation of the lira, but while revenue from domestic patients in Turkish subsidiary Acibadem shrank between 2017 and 2020, it grew in 2021, up 16.9% year-on-year.
March 17, 2022

Merger set to create €2bn revenue German hospital giant

Two of Germany’s largest not-for-profit hospitals are set to merge and form a chain to rival the likes of Helios, Sana Kliniken and Asklepios. Should these large for-profits be worried? HBI speaks with Dr Günter Merschbächer, Managing Director at one of the groups, not-for-profit Marienhaus, to find out more.
March 17, 2022

Big year for Atrys Health

Spanish multinational diagnostics and radiotherapy group Atrys Health has a phenomenal final year on the BMEGrowth market, before making the jump to the main Spanish stock exchange in February 2022. 
March 17, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us